Bonilla-Escobar F, Sawyer C, Yang P, Pepple K
Am J Ophthalmol Case Rep. 2025; 37:102252.
PMID: 39944181
PMC: 11815693.
DOI: 10.1016/j.ajoc.2025.102252.
Yang P, Mustafi D, Pepple K
Cold Spring Harb Perspect Med. 2023; 14(1.
PMID: 37037600
PMC: 10562523.
DOI: 10.1101/cshperspect.a041305.
Park E, Huckfeldt R, Comander J, Sobrin L
J Vitreoretin Dis. 2023; 5(2):147-156.
PMID: 37009079
PMC: 9979058.
DOI: 10.1177/2474126420951988.
Deng S, Huang S, Yang A, Muir E
Magn Reson Imaging. 2023; 101:47-53.
PMID: 36965834
PMC: 11104035.
DOI: 10.1016/j.mri.2023.03.017.
Fernandez-Sanchez L, Albertos-Arranz H, Ortuno-Lizaran I, Lax P, Cuenca N
Front Neuroanat. 2022; 16:858073.
PMID: 35493706
PMC: 9039202.
DOI: 10.3389/fnana.2022.858073.
Prevalence and associated relating factors in patients with hereditary retinal dystrophy: a nationwide population-based study in Taiwan.
Woon P, Chien J, Wang J, Chou Y, Lin M, Huang S
BMJ Open. 2022; 12(4):e054111.
PMID: 35396285
PMC: 8995947.
DOI: 10.1136/bmjopen-2021-054111.
Retinal Vascular Degeneration in the Transgenic P23H Rat Model of Retinitis Pigmentosa.
Fernandez-Sanchez L, Esquiva G, Pinilla I, Lax P, Cuenca N
Front Neuroanat. 2018; 12:55.
PMID: 30008665
PMC: 6034000.
DOI: 10.3389/fnana.2018.00055.
Retinal pigmentary changes in chronic uveitis mimicking retinitis pigmentosa.
Sevgi D, Davoudi S, Comander J, Sobrin L
Graefes Arch Clin Exp Ophthalmol. 2017; 255(9):1801-1810.
PMID: 28523457
DOI: 10.1007/s00417-017-3689-7.
Safety evaluation of "retina implant alpha IMS"--a prospective clinical trial.
Kitiratschky V, Stingl K, Wilhelm B, Peters T, Besch D, Sachs H
Graefes Arch Clin Exp Ophthalmol. 2014; 253(3):381-7.
PMID: 25219982
DOI: 10.1007/s00417-014-2797-x.
The relationship of central foveal thickness to urinary iodine concentration in retinitis pigmentosa with or without cystoid macular edema.
Sandberg M, Pearce E, Harper S, Weigel-DiFranco C, Hart L, Rosner B
JAMA Ophthalmol. 2014; 132(10):1209-14.
PMID: 24993773
PMC: 4192011.
DOI: 10.1001/jamaophthalmol.2014.1726.
Cystoid macular edema in retinitis pigmentosa patients without associated macular thickening.
Gorovoy I, Gallagher D, Eller A, Mayercik V, Friberg T, Schuman J
Semin Ophthalmol. 2013; 28(2):79-83.
PMID: 23448561
PMC: 5536830.
DOI: 10.3109/08820538.2012.760614.
Angiographic findings following tack fixation of a wireless epiretinal retina implant device in blind RP patients.
Roessler G, Laube T, Brockmann C, Kirschkamp T, Mazinani B, Menzel-Severing J
Graefes Arch Clin Exp Ophthalmol. 2011; 249(9):1281-6.
PMID: 21465287
DOI: 10.1007/s00417-011-1653-5.
Tangential vitreous traction: a possible mechanism of development of cystoid macular edema in retinitis pigmentosa.
Takezawa M, Tetsuka S, Kakehashi A
Clin Ophthalmol. 2011; 5:245-8.
PMID: 21386918
PMC: 3046995.
DOI: 10.2147/OPTH.S16891.
Visual acuity is related to parafoveal retinal thickness in patients with retinitis pigmentosa and macular cysts.
Sandberg M, Brockhurst R, Gaudio A, Berson E
Invest Ophthalmol Vis Sci. 2008; 49(10):4568-72.
PMID: 18552390
PMC: 2581420.
DOI: 10.1167/iovs.08-1992.
Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Fishman G, Apushkin M
Br J Ophthalmol. 2007; 91(6):743-5.
PMID: 17215269
PMC: 1955610.
DOI: 10.1136/bjo.2006.107466.
Outcome of cataract surgery in patients with retinitis pigmentosa.
Jackson H, Garway-Heath D, Rosen P, Bird A, Tuft S
Br J Ophthalmol. 2001; 85(8):936-8.
PMID: 11466249
PMC: 1724090.
DOI: 10.1136/bjo.85.8.936.
The role of carbonic anhydrase inhibitors in the management of macular edema.
Wolfensberger T
Doc Ophthalmol. 2000; 97(3-4):387-97.
PMID: 10896355
DOI: 10.1023/a:1002143802926.
The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.
Flach A
Trans Am Ophthalmol Soc. 1999; 96:557-634.
PMID: 10360304
PMC: 1298410.
Correlations between electroretinography, morphology and function in retinitis pigmentosa.
Fahle M, Steuhl K, AULHORN E
Graefes Arch Clin Exp Ophthalmol. 1991; 229(1):37-49.
PMID: 2004721
DOI: 10.1007/BF00172259.